US demand for pharmaceutical chemicals will rise 6.5 percent annually to $46.9 billion in 2019. Hormones will be the fastest growing products, led by active ingredients of anticancer, antidiabetic, and hormone replacement formulations. Central nervous system chemicals will remain the largest segment, and will be the second fastest growing.This study analyzes the $34.2 billion US pharmaceutical chemical industry. It presents historical demand data (2004, 2009 and 2014) and forecasts (2019 and 2024) by chemical type (e.g., central nervous system, hormones and related, cardiovascular, anti-infective, nutritional, biological, respiratory, gastrointestinal, dermatological).The study also considers market environment factors, details industry structure, evaluates company market share, and profiles 31 industry participants, including Teva Pharmaceutical Industries, Royal DSM, and Aurobindo Pharma.
Freedonia Market Research—Reports provide industry insights targeting market size, product and market segmentation, product and market forecasts, industry composition, market leaders and business trends.
Any questions about the report you're considering?
Our Customer Service Team can help! Or visit our FAQs.
Search all our
from one place.